[Dacarbazine (DTIC) therapy and the Budd-Chiari syndrome].
A case of a 58 years old female is presented, who died because of a Budd-Chiari-syndrome. This complication had developed during treatment with Dacarbazine (DTIC), which was given after surgical removal of a malignant melanoma. The causative relation between the Budd-Chiari-syndrome and this cytostatic drug is discussed, even though the influence of other drugs cannot be excluded.
D006502:Budd-Chiari Syndrome / Q000139:chemically induced*; D003606:Dacarbazine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008545:Melanoma / Q000188:drug therapy; D008875:Middle Aged
D003606:Dacarbazine
Dacarbazin (DTIC)-Therapie und Budd-Chiari-Syndrom.